Consonance Capital Management LP - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 60 filers reported holding CASI PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Consonance Capital Management LP ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,860,000
-88.4%
1,563,003
-84.9%
1.02%
-47.1%
Q2 2021$15,999,000
-36.8%
10,321,956
-2.1%
1.92%
-28.6%
Q1 2021$25,298,000
+13.2%
10,540,715
+39.1%
2.70%
+29.2%
Q4 2020$22,350,000
+122.7%
7,576,431
+15.5%
2.09%
+70.6%
Q3 2020$10,037,0006,560,0001.22%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Wellington Shields & Co., LLC 896,137$4,185,0002.27%
Wellington Shields Capital Management, LLC 888,333$4,149,0000.67%
Manatuck Hill Partners, LLC 15,090$70,0000.03%
IHT Wealth Management, LLC 10,725$50,0000.01%
Perceptive Advisors 43,682$204,0000.01%
ALPS ADVISORS INC 153,234$716,0000.01%
ROYCE & ASSOCIATES LP 78,742$368,0000.00%
MEEDER ASSET MANAGEMENT INC 5,863$28,0000.00%
Tower Research Capital LLC (TRC) 5,974$28,0000.00%
METROPOLITAN LIFE INSURANCE CO/NY 18,585$86,7920.00%
View complete list of CASI PHARMACEUTICALS INC shareholders